Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-14
2009-08-04
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S426000
Reexamination Certificate
active
07569601
ABSTRACT:
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
REFERENCES:
patent: 3287397 (1966-11-01), Ollson et al.
patent: 3760007 (1973-09-01), Steinman
patent: 3936493 (1976-02-01), Karmas
patent: 4857516 (1989-08-01), Terao et al.
patent: 5432175 (1995-07-01), Piwinski et al.
patent: 5686460 (1997-11-01), Nicolai et al.
patent: 6043279 (2000-03-01), Boehm et al.
patent: 6455545 (2002-09-01), Delorme et al.
patent: 2001/0021715 (2001-09-01), Delorme et al.
patent: 2002/0115662 (2002-08-01), Boyd et al.
patent: 9348934 (1994-04-01), None
patent: 308839 (1981-03-01), None
patent: 392805 (1990-04-01), None
patent: 2264263 (1990-10-01), None
patent: 2285356 (1990-11-01), None
patent: 3015853 (1991-01-01), None
patent: 3158852 (1991-07-01), None
patent: 06051546 (1994-02-01), None
patent: 06332206 (1994-12-01), None
patent: 2002008865 (2002-01-01), None
patent: 9219585 (1992-11-01), None
patent: 9415901 (1994-07-01), None
patent: 9703046 (1997-01-01), None
patent: 9857922 (1998-12-01), None
patent: 01/36360 (2001-05-01), None
patent: 0244141 (2002-06-01), None
patent: 03016270 (2003-02-01), None
Gilbert, Jacques et al.; Cytotoxicity and Antiestrogenicity of a Novel Series of Basic Diphenylethylenes; Journal of Medicinal Chemistry; 1997; 40; 1104-1111.
Garg S. et al.; Structure-Activity Relationship of Estrogens: A Study Involving Cyclofenyl As The Model Compound; J. Steroid Biochem.; 1983; 18; 89-95.
Laios I. et al.; Mechanisms Governing the Accumulation of Estrogen Receptor Alpha in MCF-7 Breast Cancer Cells Treated with Hydroxytamoxifen and Related Antiestrogens; Journal of Steroid Biochemistry & Molecular Biology; 2003; 87; 207-221.
Watts C.K.W. et al.; Studies on the Ligand Specificity and Potential Identity of Microsomal Antiestrogen-Binding Sites; Molecular Pharmacology; 1987; 31; 541-551.
Database Search Conducted By GlaxoSmithKline, Mar. 27, 2003.
Durani S. et al.; A Possible Basis for Structure-Function Relationship of Estrogens; International Journal of Quantum Chemistry; 1981; XX; 71-83.
Muthyala et al.; Bridged Bicycle Cores Containing a 1,1-Diarylene Motif Are High-Affinity Subtype-Selective Ligands for the Estrogen Receptor; J Med Chem; Apr. 2, 2003; vol. 46; 1589-1602.
Rubin et al.; Identification of New Triarylethylene Oxyalkanioc Acid Analogues as Bone Selectivo Estrogen Mimics; Bioorganic & Medicinal Chemistry; 2001; 9; 1579-1587; Elsevier Science Ltd.
Gilbert, Jacques et al.; Inhibition of Prostaglandin synthetase by di- and triphenylethylene derivative: a structure-activity study; Journal of Medicinal Chemistry; 1983; 26(5); 693-9.
Jendralla, H. et al.; Synthesis and biological activity of new HMG-CoA reductase inhibitors, 3, Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids; Journal of Medicinal Chemistry; 1991; 34(10); 2962-83.
Lubczyk et al.; Investigations on Estrogen Receptor Binding. The Estrogenic, Antiestrogenic, and Cytotoxic Properties of C2-Alkyl-Substituted 1,1-Bis(4-hydroxyphenyl)-2-phenylthenes; Journal of Medicinal Chemistry; 2002; 45; 5358-5364.
Wallace et al.; A Selective Estrogen Receptor Modulator for the Treatment of Hot Flushes; Journal of Medicinal Chemistry; 2006; 49; 843-846; American Chemical Society.
Fang Jing
Heyer Dennis
Katamreddy Subba Reddy
Miller Aaron Bayne
Navas, III Frank
SmithKline Beecham Corporation
Solola Taofiq A
Young J. Scott
LandOfFree
Cycloalkylidene compounds as modulators of estrogen receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkylidene compounds as modulators of estrogen receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkylidene compounds as modulators of estrogen receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066803